Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of iloperidone for uncontrolled hypertension; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloperidone (iloperidone)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Hypertension, Uncontrolled Hypertension | Phase 2 | Status: RECRUITING